The effects of acute nicotine administration on cognitive and early sensory processes in schizophrenia: a systematic review

Neurosci Biobehav Rev. 2020 Nov:118:121-133. doi: 10.1016/j.neubiorev.2020.07.035. Epub 2020 Jul 30.

Abstract

Nicotine use, which is mostly done through smoking tobacco, is among the most burdensome comorbidities of schizophrenia. However, the ways in which nicotine affects the cognitive and early sensory alterations found in this illness are still debated. After conducting a systematic literature search, 29 studies were selected. These studies involve individuals with schizophrenia who underwent cognitive and/or early sensory function assessments after acute nicotine administration and include 560 schizophrenia subjects and 346 non-schizophrenia controls. The findings highlight that a single dose of nicotine can improve a range of cognitive functions in schizophrenia subjects, such as attention, working memory, and executive functions, with attention being the most responsive domain. In addition, nicotine can modulate early detection of changes in the sensory environment at both the auditory and visual levels. Nevertheless, effects vary strongly depending on the type of neuropsychological assessment and nicotine intake conditions used in each study. The current findings suggest the need to consider a potential decrease of cognitive and early sensory performance when patients with schizophrenia quit smoking.

Keywords: Cognition; Early sensory; Nicotine; Review; Schizophrenia.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Cognition
  • Humans
  • Neuropsychological Tests
  • Nicotine*
  • Schizophrenia* / drug therapy
  • Sensation

Substances

  • Nicotine